Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Acta Vet Hung ; 71(3-4): 174-182, 2024 Jan 09.
Article in English | MEDLINE | ID: mdl-38090953

ABSTRACT

We aimed to assess the usefulness of monitoring inter-alpha trypsin inhibitor heavy chain 4 (ITIH4) and haptoglobin (Hp) in peripheral and local blood in canine pyometra, and evaluation the relationships among acute phase proteins (APPs), systemic inflammatory response syndrome (SIRS) and the presence of bacteria. The material was collected from bitches with pyometra and from healthy ones. Blood was taken from the cephalic and uterine veins. APPs levels were quantified by ELISA. In the peripheral circulation, the Hp was higher in animals with open-cervix pyometra (OCP) than in the closed-cervix pyometra (CCP) and the control group. The Hp concentration was not correlated with age, with the presence of SIRS or with the type of bacteria (Gram-negative, Gram-positive or mixed flora). The ITIH4 concentrations in the peripheral blood did not differ significantly in the cases of pyometra. The Hp concentration in the local circulation increased in the OCP but not in the CCP groups, although the histopathological changes in the endometrium were similar. Peripheral Hp concentrations may be a useful tool in differentiating between the types of pyometra.


Subject(s)
Dog Diseases , Pyometra , Female , Animals , Dogs , Pyometra/veterinary , Haptoglobins/metabolism , Trypsin Inhibitors , Uterus , Systemic Inflammatory Response Syndrome/veterinary , Dog Diseases/metabolism
2.
Vet Clin Pathol ; 52 Suppl 1: 64-74, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36328958

ABSTRACT

BACKGROUND: Good strategical programs are required for the early detection of disease even in the absence of evident clinical signs, which is crucial in satisfying animal welfare. Haptoglobin (Hp) and inter-α-trypsin inhibitor heavy chain H4 (ITIH4) are acute phase proteins and good biomarkers of early inflammation in cattle, with plasma levels that significantly increase after injury or infection. OBJECTIVES: We aimed to develop and validate two new immunoturbidimetric methods for Hp and ITIH4. METHODS: Species-specific antibodies were obtained and used to develop the immunoassays. For the Hp assay, antibodies were fixed to latex microparticles to enhance detection. The immunoassays were set up in an automated analyzer to carry out validation studies. Reference intervals were calculated using Reference Value Advisor. RESULTS: The Hp immunoturbidimetric method had a linear analytical range up to 0.40 mg/mL. The limit of detection (LoD) was 0.005 mg/mL, and the limit of quantification (LoQ) was 0.007 mg/mL. Total imprecision was less than 7%. Comparison with ELISA and single radial immunodiffusion (SRID) showed good correlation, whereas the comparison with the colorimetric method showed constant and proportional differences. The ITIH4 immunoassay showed linearity up to 5 mg/mL, and the LoD was 0.002 mg/mL. Total imprecision was less than 6%. Method comparison showed a good correlation with single radial immunodiffusion, both methods being equivalent. Bilirubin, triglycerides, and hemoglobin presented no interference in any of the assays. Reference intervals were 0.007-0.017 mg/mL for Hp and 0.2-0.7 mg/mL for ITIH4 in dairy cows 10 days before parturition. CONCLUSIONS: Immunoturbidimetric methods developed for Hp and ITIH4 can measure basal and increased levels of these proteins, showing adequate precision, accuracy, and robustness.


Subject(s)
Haptoglobins , Immunoturbidimetry , Female , Cattle , Animals , Immunoturbidimetry/veterinary , Alpha-Globulins/analysis , Acute-Phase Proteins , Antibodies
3.
J AOAC Int ; 104(5): 1289-1297, 2021 Sep 27.
Article in English | MEDLINE | ID: mdl-33909888

ABSTRACT

BACKGROUND: The Eclipse Farm 4G test coupled to the COMET device allows for automatic and easy screening of a broad range of antimicrobials in raw bovine milk. All results obtained with this system are available in real-time through a smartphone application (App) and in the Test4all cloud platform. OBJECTIVE: The objective of this study was to validate Eclipse Farm 4G & COMET for the screening of antimicrobials in raw bovine milk according to AOAC Performance Tested MethodSM procedures. METHOD: The test is based on the inhibition of microbial growth of Geobacillus stearothermophilus in the presence of antimicrobials. When sample tubes are incubated in the absence of antibiotics, spores germinate and cells grow, changing the medium color from purple to yellow (negative result). The presence of antimicrobials in the milk sample hinders bacterial growth, preventing the tubes from changing color from purple to yellow (positive result). The COMET device automatically integrates all assay steps (incubation, time control, and results interpretation) and communications between the device, smartphone, and cloud. RESULTS: LODs and detection capabilities were confirmed to be at or below the European Union (EU) maximum residue limit (MRL) for most of the evaluated molecules representing the main families of antimicrobials (penicillins, cephalosporins, tetracyclines, sulfonamides, macrolides, and aminoglycosides). False-positive rates and the effect of potentially interfering substances showed sufficient selectivity/specificity. The Eclipse Farm 4G & COMET system was shown to be robust, consistent, and stable during shelf life. CONCLUSIONS: The Eclipse Farm 4G & COMET system has been shown to be suitable for screening antibiotics in raw bovine milk. HIGHLIGHTS: The assay is an automatic and easy system for the detection of a broad range of antibiotics in raw bovine milk consistent with EU MRLs and can provide results any time and anywhere through a smartphone App and a cloud platform.


Subject(s)
Anti-Bacterial Agents , Drug Residues , Animals , Anti-Bacterial Agents/analysis , Cattle , Drug Residues/analysis , Farms , Food Contamination/analysis , Milk/chemistry , Sensitivity and Specificity
4.
Vet Immunol Immunopathol ; 235: 110221, 2021 May.
Article in English | MEDLINE | ID: mdl-33730638

ABSTRACT

Measurement of acute phase proteins (APPs) as biomarkers in canine medicine is in increasing demand. In the present study, the development and validation of two ELISA methods for the quantification of canine inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) and haptoglobin (Hp) are shown. The adequate imprecision and accuracy and wide analytical range make the developed methods appropriate to quantify ITIH4 and Hp in serum samples. The inter- and intra-assay CVs were lower than 10 %, and the assays maintained linearity under dilution and showed analytical equivalence with the method of radial immunodiffusion. The measurement of CRP, Hp and ITIH4 in sera from bitches affected by pyometra allowed us to determine that ITIH4 behaves as a moderate APP in dogs. The group of bitches affected by pyometra showed very high levels of CRP (147 ± 91 mg/L), corresponding to a strong inflammatory process, which resulted in a moderate increase in the concentrations of Hp (7 times) and ITIH4 (3 times) compared to the control group.


Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/veterinary , Glycoproteins/blood , Haptoglobins/analysis , Pyometra/blood , Pyometra/veterinary , Acute-Phase Proteins/analysis , Acute-Phase Proteins/classification , Animals , Biomarkers/blood , C-Reactive Protein/analysis , Dogs , Female , Inflammation/blood
5.
Vet Immunol Immunopathol ; 217: 109922, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31450165

ABSTRACT

Inter alpha trypsin inhibitor heavy chain 4 (ITIH4) is a serum protein belonging to the Inter alpha trypsin inhibitor (ITI) family, which was previously characterized by our group as a new APP in cattle. This protein was firstly described in pigs where is known to be a major acute phase protein, also denominated Pig-MAP. Increases of ITIH4 of up to 12 times the pre-infection values were previously reported in the serum of heifers with experimentally induced summer mastitis. ITIH4 was detected in the milk of cows with mastitis by western blot, but the method previously used to quantify this protein, radial immunodiffusion, was not sensitive enough to quantify it in milk samples. In this study we developed an ELISA method which allows the quantification of bovine ITIH4 in serum and milk samples. Previously developed antibodies were used to perform the assay, including anti bovine ITIH4 polyclonal antibodies and a monoclonal antibody against pig ITIH4 that also recognizes the bovine homologous protein. The ELISA developed showed an adequate precision, with inter and intra- assay coefficients of variation lower than 10% for serum and milk samples. The assay keeps linearity under dilution for both serum and milk samples. A good agreement was observed between the values measured by ELISA and radial immunodiffusion in serum samples.


Subject(s)
Enzyme-Linked Immunosorbent Assay/veterinary , Milk/chemistry , Proteinase Inhibitory Proteins, Secretory/blood , Acute-Phase Proteins/immunology , Animals , Antibodies/immunology , Antibodies, Monoclonal/immunology , Cattle , Female , Mastitis/blood , Proteinase Inhibitory Proteins, Secretory/immunology , Reproducibility of Results , Sensitivity and Specificity
6.
J Dairy Sci ; 102(1): 539-546, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30343922

ABSTRACT

The aim of the study was to investigate the concentrations of acute-phase inter-α-trypsin inhibitor heavy chain 4 (ITIH4) in serum and milk of cows with subclinical mastitis caused by Streptococcus spp. (STR) and coagulase-negative Staphylococcus spp. (CNS) and healthy cows. The blood and milk samples were obtained from 60 mid-lactation, multiparous Holstein-Friesian cows from 7 herds in the Lublin region of Poland. In the milk samples from 40 cows with subclinical mastitis, Streptococcus spp. and CNS were isolated. The ITIH4 was significantly higher in serum of cows with subclinical mastitis caused both by STR and CNS compared with healthy cows. One hundred percent of animals infected with Streptococcus spp. and 89% of animals infected with Staphylococcus spp. showed ITIH4 concentration in sera higher than 0.5 mg/mL. The concentration of ITIH4 in milk also was significantly higher in cows with subclinical mastitis caused by Streptococcus spp. and Staphylococcus spp. compared with the control group. Seventy percent of cows infected by STR and CNS showed ITIH4 concentration in milk higher than 2.5 µg/mL. Milk ITIH4 concentration higher than 5 µg/mL was found in 55% of animals infected with Streptococcus spp. and in 40% of animals infected with Staphylococcus spp. No statistically significant differences were observed in ITIH4 concentrations both in serum and in milk between the studied unhealthy animal groups. These results suggest that ITIH4 may be used in the future as a novel diagnostic marker in serum and in milk of subclinical mastitis in cows.


Subject(s)
Alpha-Globulins/analysis , Mastitis, Bovine/blood , Milk/chemistry , Staphylococcal Infections/veterinary , Streptococcal Infections/veterinary , Alpha-Globulins/metabolism , Animals , Cattle , Coagulase/analysis , Coagulase/metabolism , Female , Lactation , Mastitis, Bovine/microbiology , Mastitis, Bovine/physiopathology , Milk/metabolism , Poland , Serum/chemistry , Staphylococcal Infections/blood , Staphylococcal Infections/microbiology , Staphylococcal Infections/physiopathology , Staphylococcus/enzymology , Staphylococcus/physiology , Streptococcal Infections/blood , Streptococcal Infections/microbiology , Streptococcal Infections/physiopathology , Streptococcus/physiology
7.
Vet Clin Pathol ; 47(1): 122-129, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29575137

ABSTRACT

BACKGROUND: The availability of a species-specific reference material is essential for the harmonization of results obtained in different laboratories by different methods. OBJECTIVES: We describe the preparation of a canine C-reactive protein (cCRP) serum reference material containing purified cCRP stabilized in a serum matrix. The material can be used by manufacturers to assign values to their calibrator and control materials. METHODS: The serum matrix was obtained using blood collected from healthy dogs, stabilized and submitted for a delipidation process. The reference material was prepared by diluting purified cCRP in the serum matrix containing 1.0 mol/L HEPES buffer, 3.0 mmol/L calcium chloride, 80,000 kUI/L aprotinin, and 1.0 mmol/L benzamidine hydrochloride monohydrate at a pH of 7.2, and dispensing (0.5 mL) the matrix into vials that were then frozen. RESULTS: The pilot batch of 200 vials was shown to be homogeneous and stable after a stability study at various temperatures and over a total time of 110 days. The prepared material was submitted to an assignment value study. Eight laboratories from different European countries participated by using the same reagents for an immunoturbidimetric method adapted for different analyzers. The obtained cCRP concentration in the reference material was 78.5 mg/L with an expanded uncertainty (k = 2) of 4.2 mg/L. CONCLUSIONS: Canine C-reactive protein serum reference material has been produced that allows harmonization of results obtained by different methods and different laboratories, thus reducing the possibility of errors and misunderstandings.


Subject(s)
C-Reactive Protein/analysis , Dogs/blood , Animals , Feasibility Studies , Reference Standards , Species Specificity
8.
Vet Clin Pathol ; 47(1): 130-137, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29377276

ABSTRACT

BACKGROUND: In dogs, as in humans, C-reactive protein (CRP) is a major acute phase protein that is rapidly and prominently increased after exposure to inflammatory stimuli. CRP measurements are used in the diagnosis and monitoring of infectious and inflammatory diseases. OBJECTIVES: The study aim was to develop and validate a turbidimetric immunoassay for the quantification of canine CRP (cCRP), using canine-specific reagents and standards. METHODS: A particle-enhanced turbidimetric immunoassay was developed. The assay was set up in a fully automated analyzer, and studies of imprecision, limits of linearity, limits of detection, prozone effects, and interferences were carried out. The new method was compared with 2 other commercially available automated immunoassays for cCRP: one turbidimetric immunoassay (Gentian CRP) and one point-of-care assay based on magnetic permeability (Life Assays CRP). RESULTS: The within-run and between-day imprecision were <1.7% and 4.2%, respectively. The assay quantified CRP proportionally in an analytic range up to 150 mg/L, with a prozone effect appearing at cCRP concentrations >320 mg/L. No interference from hemoglobin (20 g/L), triglycerides (10 g/L), or bilirubin (150 mg/L) was detected. Good agreement was observed between the results obtained with the new method and the Gentian cCRP turbidimetric immunoassay. CONCLUSIONS: The new turbidimetric immunoassay (Turbovet canine CRP, Acuvet Biotech) is a rapid, robust, precise, and accurate method for the quantification of cCRP. The method can be easily set up in automated analyzers, providing a suitable tool for routine clinical use.


Subject(s)
C-Reactive Protein/analysis , Dogs/blood , Immunoturbidimetry/veterinary , Animals , Automation , Immunoturbidimetry/methods , Reference Values
9.
Vet Immunol Immunopathol ; 182: 74-78, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27863554

ABSTRACT

Acute phase proteins are useful inflammatory markers in horses. Haptoglobin (Hp) serum level is increased in horses undergoing different inflammatory processes, including arthritis. However, Hp concentration has not been assessed in inflammatory synovial fluid (SF). The aim of the present study was to investigate the Hp response in serum and SF in horses undergoing experimentally induced arthritis. For this purpose, serum and SF samples were collected from 12 animals before amphotericin B-induced arthritis was created (T0, healthy) and 15days after the lesion induction (T1, joint inflammation) and Hp was determined by single radial immunodiffusion. The Hp increase between T0 and T1 was significant in both serum and SF, and serum Hp concentration at T0 was significantly higher than in SF, but significant differences were not found at T1, indicating a higher Hp increase in SF. A significant positive correlation for Hp concentration between serum and SF samples was found. These results highlight the potential usefulness of Hp as inflammatory marker in horses, showing for the first time the increase of Hp in SF from joint inflammation in the horse.


Subject(s)
Arthritis/veterinary , Haptoglobins/metabolism , Horse Diseases/blood , Horse Diseases/metabolism , Animals , Arthritis/blood , Arthritis/metabolism , Arthritis, Experimental/blood , Arthritis, Experimental/metabolism , Biomarkers/blood , Biomarkers/metabolism , Horses , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Male , Synovial Fluid/metabolism , Time Factors
10.
Infect Control Hosp Epidemiol ; 27(12): 1299-303, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17152026

ABSTRACT

OBJECTIVE: We estimated the impact of hip replacement-associated surgical site infection (SSI) on morbidity and length of stay. METHODS: This was a pairwise matched (1 : 1) case-control study nested in a cohort. All patients who underwent hip replacement from January 1, 2000, to June 30, 2004, were prospectively enrolled for the nested case-control design analysis and were monitored from the time of surgery until hospital discharge, including any patients readmitted because of infection. RESULTS: Among the 1,260 hip replacements performed, 28 SSIs were detected, yielding a crude SSI rate of 2.2%. The median excess length of stay attributable to SSI was 32.5 days (P<.001), whereas the median prolonged postoperative stay due to SSI was 31 days (P<.001). Deep-wound SSI was the type that prolonged hospital stay the most (up to 49 days). Of the patients who developed an SSI, 4 required revision surgery, for an SSI-related morbidity rate of 14.3%. CONCLUSION: SSI prolongs hospital stay; however, although hospital stay is a rough indicator of the cost of this complication, to accurately estimate the costs of SSI, we would need to consider individual costs in a linear regression model adjusted for all possible confounding factors.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Cross Infection/economics , Surgical Wound Infection/economics , Arthroplasty, Replacement, Hip/mortality , Case-Control Studies , Cross Infection/complications , Cross Infection/mortality , Humans , Length of Stay/economics , Length of Stay/statistics & numerical data , Surgical Wound Infection/complications , Surgical Wound Infection/epidemiology , Surgical Wound Infection/etiology , Surgical Wound Infection/mortality , Surgical Wound Infection/prevention & control
11.
Am J Infect Control ; 34(3): 134-41, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16630977

ABSTRACT

BACKGROUND: In 1997, a national standardized surveillance system for nosocomial infections (NI) in surgery patients was established in Spain. This system, known as the VICONOS program, is based on the US National Nosocomial Infection Surveillance System (NNISS). Herein, we present a summary of the data collected from January 1997 to December 2003. METHODS: VICONOS actively monitors all patients referred to the surgery ward of each participating hospital. The criteria used to define surgical site infection (SSI), patient risk index category, and surgical procedures used are those established by the Centers for Disease Control and Prevention (CDC) and the NNISS. RESULTS: SSI rates are shown by operative procedure and NNISS risk index category. Standardized infection ratios (SIR) were calculated for the 7 surgical procedures most frequently performed to compare our rates with those published by the NNISS. We provide factors that can be used as quality indicators such as rates of main surgery complications, length of hospital stay, and presurgery prophylaxis. Also described are the most used antimicrobial agents, the microorganisms most frequently isolated, and the corresponding sites. CONCLUSION: VICONOS counts on the voluntary participation of 43 Spanish public hospitals. Our immediate plans are to incorporate new surveillance components and encourage new centers to join our network.


Subject(s)
Bacterial Infections/epidemiology , Cross Infection/epidemiology , Population Surveillance/methods , Postoperative Complications/epidemiology , Surgical Wound Infection/epidemiology , Antibiotic Prophylaxis , Bacterial Infections/prevention & control , Cross Infection/prevention & control , Humans , Postoperative Complications/prevention & control , Risk Factors , Spain/epidemiology , Surgical Wound Infection/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...